Return to content in this issue


Off-label Use of Mepolizumab: A Potential Therapeutic Option for Eosinophilic Cystitis

Wang G1, Zhuo N2, Liu Z1

1Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China
2Department of Nephrology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China

J Investig Allergol Clin Immunol 2024; Vol. 34(4)
doi: 10.18176/jiaci.0973

Key words: Eosinophilic cystitis, Mepolizumab